Cart
sales@molnova.com
Ectoine
CAS No. 96702-03-3
Ectoine( Ectoine )
Catalog No. M17696 CAS No. 96702-03-3
Ectoine is an osmoprotectant in a variety of microorganisms including halophilic and heterotrophic bacteria and non-halophilic bacteria such as the Streptomyces species, as well as E.coli.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 41 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEctoine
-
NoteResearch use only, not for human use.
-
Brief DescriptionEctoine is an osmoprotectant in a variety of microorganisms including halophilic and heterotrophic bacteria and non-halophilic bacteria such as the Streptomyces species, as well as E.coli.
-
DescriptionEctoine is an inhibitor of protein misfolding. It acts by significantly down-regulating Syp, Mapk3 and Tnfα and up-regulating Vegf in rat's hippocampus, prohibiting insulin amyloid formation in vitro.(In Vitro):Ectoine (0-5% (w/v); 0-24 h; human erythrocytes) protects the cells from damage caused by SDS treatment.
-
In VitroEctoine (0-5% (w/v); 0-24 h; human erythrocytes) protects the cells from damage caused by SDS treatment.
-
In Vivo——
-
SynonymsEctoine
-
PathwayPI3K/Akt/mTOR signaling
-
TargetmTOR
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number96702-03-3
-
Formula Weight142.16
-
Molecular FormulaC6H10N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 250 mg/mL (1758.58 mM)
-
SMILESC1(=N[C@@H](CCN1)C(=O)O)C
-
Chemical Name(6S)-2-Methyl-1,4,5,6-tetrahydropyrimidine-6-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Meyer S., et al. Ectoine can enhance structural changes in DN/A in vitro. Sci Rep. 2017 Aug 3;7(1):7170.
molnova catalog
related products
-
Sapanisertib
Sapanisertib (INK-128, MLN0128) is a potent, ATP-competitive, orally active dual mTORC1/2 inhibitor with Ki of 1.4 nM in cell-free assays.
-
CNX-2006
CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.
-
DMH-25
DMH25 is a novel covalent and potent inhibitor of mTOR and shows in vivo antitumor activity against triple-negative breast cancer cells.In vivo, DHM25 was an efficient inhibitor of growth and metastasis of triple-negative breast cancer cells, paving the way for its clinical application in oncology.
